Expression of Cannabinoid CB1 Receptors by Vagal Afferent Neurons, Is Inhibited by Cholecystokinin

Journal of Neuroscience

Volumn 24, Issue 11, 2004, Pages 2708-2715

  Burdyga, Galina ^a   Lal, Simon ^a   Varro, Andrea ^a   Dimaline, Rod ^a   Thompson, David G ^b   Dockray, Graham J ^a  

^a UNIVERSITY OF LIVERPOOL   (United Kingdom)

^b UNIVERSITY OF MANCHESTER   (United Kingdom)

Author keywords

Afferent; Appetite; Cannabinoids; CCK; Cholecystokinin; Satiety; Vagus

Indexed keywords

CANNABINOID 1 RECEPTOR; CANNABINOID RECEPTOR AGONIST; CHOLECYSTOKININ; LORGLUMIDE;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DIET RESTRICTION; DUODENUM; FOOD INTAKE; GASTROINTESTINAL TRACT; HORMONE ACTION; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION; MALE; NERVE PROJECTION; NODOSE GANGLION; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SATIETY; SENSORY NERVE; STOMACH INNERVATION; VAGUS NERVE;

ANIMALS; CHOLECYSTOKININ; CULTURE TECHNIQUES; DUODENUM; FOOD DEPRIVATION; HORMONE ANTAGONISTS; HUMANS; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION; MALE; NERVE CRUSH; NEURONS, AFFERENT; NODOSE GANGLION; PROGLUMIDE; RATS; RATS, WISTAR; RECEPTOR, CANNABINOID, CB1; RECEPTOR, CANNABINOID, CB2; RECEPTOR, CHOLECYSTOKININ A; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; SATIETY RESPONSE; STOMACH; VAGUS NERVE;

EID: 1642298863     PISSN: 02706474     EISSN: None     Source Type: Journal    
DOI: 10.1523/JNEUROSCI.5404-03.2004     Document Type: Article

References (46)

1. Andrews PL (1986) Vagal afferent innervation of the gastrointestinal tract. Prog Brain Res 67:65-86.
2. Barrachina MD, Martinez V, Wang L, Wei JY, Tache Y (1997) Synergistic interaction between leptin and cholecystokinin to reduce short-term food intake in lean mice. Proc Natl Acad Sci USA 94:10455-10460.
3. Batterham RL, Cohen MA, Ellis SM, Le Roux CW, Withers DJ, Frost GS, Ghatei MA, Bloom SR (2003) Inhibition of food intake in obese subjects by peptide YY3-36. N Engl J Med 349:941-948.
4. Bouaboula M, Perrachon S, Milligan L, Canat X, Rinaldi-Carmona M, Portier M, Barth F, Calandra B, Pecceu F, Lupker J, Maffrand JP, Le Fur G, Casellas P (1997) A selective inverse agonist for central cannabinoidreceptor inhibits mitogen-activated protein kinase activation stimulated by insulin or insulin-like growth factor 1. Evidence for a new model of receptor/ligand interactions. J Biol Chem 272:22330-22339.
5. Broberger C, Hokfelt T (2001) Hypothalamic and vagal neuropeptide circuitries regulating food intake. Physiol Behav 74:669-682.
6. Broberger C, Holmberg K, Kuhar MJ, Hokfelt T (1999) Cocaine- and amphetamine-regulated transcript in the rat vagus nerve: a putative mediator of cholecystokinin-induced satiety. Proc Natl Acad Sci USA 96:13506-13511.
7. Broberger C, Holmberg K, Shi TJ, Dockray G, Hokfelt T (2001) Expression and regulation of cholecystokinin and cholecystokinin receptors in rat nodose and dorsal root ganglia. Brain Res 903:128-140.
8. Burdyga G, Spiller D, Morris R, Lal S, Thompson DG, Saeed S, Dimaline R, Varro A, Dockray GJ (2002) Expression of the leptin receptor in rat and human nodose ganglion neurones. Neuroscience 109:339-347.
9. Burdyga G, Lal S, Spiller D, Jiang W, Thompson D, Attwood S, Saeed S, Grundy D, Varro A, Dimaline R, Dockray GJ (2003) Localization of orexin-1 receptors to vagal afferent neurons in the rat and humans. Gastroenterology 124:129-139.
10. Buyse M, Ovesjo ML, Goiot H, Guilmeau S, Peranzi G, Moizo L, Walker F, Lewin MJ, Meister B, Bado A (2001) Expression and regulation of leptin receptor proteins in afferent and efferent neurons of the vagus nerve. Eur J Neurosci 14:64-72.
11. Calignano A, Katona I, Desarnaud F, Giuffrida A, La Rana G, Mackie K, Freund TF, Piomelli D (2000) Bidirectional control of airway responsiveness by endogenous cannabinoids. Nature 408:96-101.
12. Cota D, Marsicano G, Tschop M, Grubler Y, Flachskamm C, Schubert M, Auer D, Yassouridis A, Thone-Reineke C, Ortmann S, Tomassoni F, Cervino C, Nisoli E, Linthorst AC, Pasquali R, Lutz B, Stalla GK, Pagotto U (2003) The endogenous cannabinoid system affects energy balance via central orexigenic drive and peripheral lipogenesis. J Clin Invest 112:423-431.
13. Covasa M, Marcuson JK, Ritter RC (2001) Diminished satiation in rats exposed to elevated levels of endogenous or exogenous cholecystokinin. Am J Physiol Regul Integr Comp Physiol 280:R331-R337.
14. Date Y, Murakami N, Toshinai K, Matsukura S, Niijima A, Matsuo H, Kangawa K, Nakazato M (2002) The role of the gastric afferent vagal nerve in ghrelin-induced feeding and growth hormone secretion in rats. Gastroenterology 123:1120-1128.
15. Eastwood C, Maubach K, Kirkup AJ, Grundy D (1998) The role of endogenous cholecystokinin in the sensory transduction of luminal nutrient signals in the rat jejunum. Neurosci Lett 254:145-148.
16. Freund TF, Katona I, Piomelli D (2003) Role of endogenous cannabinoids in synaptic signaling. Physiol Rev 83:1017-1066.
17. Gibbs J, Young RC, Smith GP (1973) Cholecystokinin elicits satiety in rats with open gastric fistulas. Nature 245:323-325.
18. Gomez R, Navarro M, Ferrer B, Trigo JM, Bilbao A, Del Arco I, Cippitelli A, Nava F, Piomelli D, Rodriguez de Fonseca F (2002) A peripheral mechanism for CB1 cannabinoid receptor-dependent modulation of feeding. J Neurosci 22:9612-9617.
19. Green T, Dockray GJ (1988) Characterization of the peptidergic afferent innervation of the stomach in the rat, mouse and guinea-pig. Neuroscience 25:181-193.
20. Hilairet S, Bouaboula M, Carriere D, Le Fur G, Casellas P (2003) Hypersensitization of the Orexin 1 receptor by the CB1 receptor: evidence for cross-talk blocked by the specific CB1 antagonist, SR141716. J Biol Chem 278:23731-23737.
21. Holzer P (1998) Neural injury, repair, and adaptation in the GI tract. II. The elusive action of capsaicin on the vagus nerve. Am J Physiol 275:G8-13.
22. Janig W, Morrison JF (1986) Functional properties of spinal visceral afferents supplying abdominal and pelvic organs, with special emphasis on visceral nociception. Prog Brain Res 67:87-114.
23. Kojima M, Hosoda H, Date Y, Nakazato M, Matsuo H, Kangawa K (1999) Ghrelin is a growth-hormone-releasing acylated peptide from stomach. Nature 402:656-660.
24. Komaki G, Matsumoto Y, Nishikata H, Kawai K, Nozaki T, Takii M, Sogawa H, Kubo C (2001) Orexin-A and leptin change inversely in fasting non-obese subjects. Eur J Endocrinol 144:645-651.
25. Lonze BE, Ginty DD (2002) Function and regulation of CREB family transcription factors in the nervous system. Neuron 35:605-623.
26. Luckman SM, Lawrence CB (2003) Anorectic brainstem peptides: more pieces to the puzzle. Trends Endocrinol Metab 14:60-65.
27. McLaughlin J, Grazia LM, Jones MN, D'Amato M, Dockray GJ, Thompson DG (1999) Fatty acid chain length determines cholecystokinin secretion and effect on human gastric motility. Gastroenterology 116:46-53.
28. Mechoulam R, Hanu L (2001) The cannabinoids: an overview. Therapeutic implications in vomiting and nausea after cancer chemotherapy, in appetite promotion, in multiple sclerosis and in neuroprotection. Pain Res Manag 6:67-73.
29. Mercer JG, Farningham DA, Lawrence CB (1992) Effect of neonatal capsaicin treatment on cholecystokinin-(CCK8) satiety and axonal transport of CCK binding sites in the rat vagus nerve. Brain Res 569:311-316.
30. Moran TH, Norgren R, Crosby RJ, McHugh PR (1990) Central and peripheral vagal transport of cholecystokinin binding sites occurs in afferent fibers. Brain Res 526:95-102.
31. Moriarty P, Dimaline R, Thompson DG, Dockray GJ (1997) Characterization of cholecystokininA and cholecystokininB receptors expressed by vagal afferent neurons. Neuroscience 79:905-913.
32. Partosoedarso ER, Abrahams TP, Scullion RT, Moerschbaecher JM, Hornby PJ (2003) Cannabinoid1 receptor in the dorsal vagal complex modulates lower oesophageal sphincter relaxation in ferrets. J Physiol (Lond) 550:149-158.
33. Peiser C, Springer J, Groneberg DA, McGregor GP, Fischer A, Lang RE (2002) Leptin receptor expression in nodose ganglion cells projecting to the rat gastric fundus. Neurosci Lett 320:41-44.
34. Pertwee RG (1997) Pharmacology of cannabinoid CB1 and CB2 receptors. Pharmacol Ther 74:129-180.
35. Raybould HE, Gayton RJ, Dockray GJ (1988) Mechanisms of action of peripherally administered cholecystokinin octapeptide on brain stem neurons in the rat. J Neurosci 8:3018-3024.
36. Reidelberger RD, Castellanos DA, Hulce M (2003) Effects of peripheral CCK receptor blockade on food intake in rats. Am J Physiol Regul Integr Comp Physiol 285:R429-R437.
37. Ritter RC, Ladenheim EE (1985) Capsaicin pretreatment attenuates suppression of food intake by cholecystokinin. Am J Physiol 248:R501-R504.
38. Ross RA (2003) Anandamide and vanilloid TRPV1 receptors. Br J Pharmacol 140:790-801.
39. Schwartz GJ, McHugh PR, Moran TH (1993) Gastric loads and cholecystokinin synergistically stimulate rat gastric vagal afferents. Am J Physiol 265:R872-R876.
40. Schwartz MW, Woods SC, Porte D Jr, Seeley RJ, Baskin DG (2000) Central nervous system control of food intake. Nature 404:661-671.
41. Shaywitzm AJ, Greenberg ME (1999) CREB: a stimulus-induced transcription factor activated by a diverse array of extracellular signals. Annu Rev Biochem 68:821-861.
42. Smith GP, Jerome C, Cushin BJ, Eterno R, Simansky KJ (1981) Abdominal vagotomy blocks the satiety effect of cholecystokinin in the rat. Science 213:1036-1037.
43. Van Sickle MD, Oland LD, Ho W, Hillard CJ, Mackie K, Davison JS, Sharkey KA (2001) Cannabinoids inhibit emesis through CB1 receptors in the brainstem of the ferret. Gastroenterology 121:767-774.
44. Van Sickle MD, Oland LD, Mackie K, Davison JS, Sharkey KA (2003) Delta9-tetrahydrocannabinol selectively acts on CB1 receptors in specific regions of dorsal vagal complex to inhibit emesis in ferrets. Am J Physiol Gastrointest Liver Physiol 285:G566-G576.
45. Wang YH, Tache Y, Sheibel AB, Go VL, Wei JY (1997) Two types of leptin-responsive gastric vagal afferent terminals: an in vitro single-unit study in rats. Am I Physiol 273:R833-R837.
46. Zygmunt PM, Petersson J, Andersson DA, Chuang H, Sorgard M, Di Marzo V, Julius D, Hogestatt ED (1999) Vanilloid receptors on sensory nerves mediate the vasodilator action of anandamide. Nature 400:452-457.